The global market for Brompheniramine was estimated to be worth US$ 545 million in 2023 and is forecast to a readjusted size of US$ 739.7 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Brompheniramine - Market

Brompheniramine, is an antihistamine drug of the propylamine (alkylamine) class. It is readily available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine and one of the drugs of highest anticholinergic activity

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brompheniramine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Brompheniramine by region & country, by Type, and by Application.

The Brompheniramine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brompheniramine.

Market Segmentation

Scope of Brompheniramine - Market Report

Report Metric	Details
Report Name	Brompheniramine - Market
Forecasted market size in 2030	US$ 739.7 million
CAGR	4.5%
Forecasted years	2024 - 2030
Segment by Type:	Oral Solution Tablet
Segment by Application	Hospital Drug Store
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, Endo International, Novartis, Eon Pharma, Merck, Tanta Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Brompheniramine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Brompheniramine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Brompheniramine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Brompheniramine - Market size in 2030?

Ans: The Brompheniramine - Market size in 2030 will be US$ 739.7 million.

Who are the main players in the Brompheniramine - Market report?

Ans: The main players in the Brompheniramine - Market are Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, Endo International, Novartis, Eon Pharma, Merck, Tanta Pharmaceuticals

What are the Application segmentation covered in the Brompheniramine - Market report?

Ans: The Applications covered in the Brompheniramine - Market report are Hospital, Drug Store

What are the Type segmentation covered in the Brompheniramine - Market report?

Ans: The Types covered in the Brompheniramine - Market report are Oral Solution, Tablet

1 Market Overview

1.1 Brompheniramine Product Introduction

1.2 Global Brompheniramine Market Size Forecast

1.2.1 Global Brompheniramine Sales Value (2019-2030)

1.2.2 Global Brompheniramine Sales Volume (2019-2030)

1.2.3 Global Brompheniramine Sales Price (2019-2030)

1.3 Brompheniramine Market Trends & Drivers

1.3.1 Brompheniramine Industry Trends

1.3.2 Brompheniramine Market Drivers & Opportunity

1.3.3 Brompheniramine Market Challenges

1.3.4 Brompheniramine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Brompheniramine Players Revenue Ranking (2023)

2.2 Global Brompheniramine Revenue by Company (2019-2024)

2.3 Global Brompheniramine Players Sales Volume Ranking (2023)

2.4 Global Brompheniramine Sales Volume by Company Players (2019-2024)

2.5 Global Brompheniramine Average Price by Company (2019-2024)

2.6 Key Manufacturers Brompheniramine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Brompheniramine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Brompheniramine

2.9 Brompheniramine Market Competitive Analysis

2.9.1 Brompheniramine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Brompheniramine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brompheniramine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral Solution

3.1.2 Tablet

3.2 Global Brompheniramine Sales Value by Type

3.2.1 Global Brompheniramine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Brompheniramine Sales Value, by Type (2019-2030)

3.2.3 Global Brompheniramine Sales Value, by Type (%) (2019-2030)

3.3 Global Brompheniramine Sales Volume by Type

3.3.1 Global Brompheniramine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Brompheniramine Sales Volume, by Type (2019-2030)

3.3.3 Global Brompheniramine Sales Volume, by Type (%) (2019-2030)

3.4 Global Brompheniramine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Drug Store

4.2 Global Brompheniramine Sales Value by Application

4.2.1 Global Brompheniramine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Brompheniramine Sales Value, by Application (2019-2030)

4.2.3 Global Brompheniramine Sales Value, by Application (%) (2019-2030)

4.3 Global Brompheniramine Sales Volume by Application

4.3.1 Global Brompheniramine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Brompheniramine Sales Volume, by Application (2019-2030)

4.3.3 Global Brompheniramine Sales Volume, by Application (%) (2019-2030)

4.4 Global Brompheniramine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Brompheniramine Sales Value by Region

5.1.1 Global Brompheniramine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Brompheniramine Sales Value by Region (2019-2024)

5.1.3 Global Brompheniramine Sales Value by Region (2025-2030)

5.1.4 Global Brompheniramine Sales Value by Region (%), (2019-2030)

5.2 Global Brompheniramine Sales Volume by Region

5.2.1 Global Brompheniramine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Brompheniramine Sales Volume by Region (2019-2024)

5.2.3 Global Brompheniramine Sales Volume by Region (2025-2030)

5.2.4 Global Brompheniramine Sales Volume by Region (%), (2019-2030)

5.3 Global Brompheniramine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Brompheniramine Sales Value, 2019-2030

5.4.2 North America Brompheniramine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Brompheniramine Sales Value, 2019-2030

5.5.2 Europe Brompheniramine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Brompheniramine Sales Value, 2019-2030

5.6.2 Asia Pacific Brompheniramine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Brompheniramine Sales Value, 2019-2030

5.7.2 South America Brompheniramine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Brompheniramine Sales Value, 2019-2030

5.8.2 Middle East & Africa Brompheniramine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Brompheniramine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Brompheniramine Sales Value

6.2.1 Key Countries/Regions Brompheniramine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Brompheniramine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Brompheniramine Sales Value, 2019-2030

6.3.2 United States Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Brompheniramine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Brompheniramine Sales Value, 2019-2030

6.4.2 Europe Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Brompheniramine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Brompheniramine Sales Value, 2019-2030

6.5.2 China Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Brompheniramine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Brompheniramine Sales Value, 2019-2030

6.6.2 Japan Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Brompheniramine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Brompheniramine Sales Value, 2019-2030

6.7.2 South Korea Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Brompheniramine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Brompheniramine Sales Value, 2019-2030

6.8.2 Southeast Asia Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Brompheniramine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Brompheniramine Sales Value, 2019-2030

6.9.2 India Brompheniramine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Brompheniramine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Company Information

7.1.2 Pfizer Introduction and Business Overview

7.1.3 Pfizer Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Pfizer Brompheniramine Product Offerings

7.1.5 Pfizer Recent Development

7.2 AMAG Pharmaceuticals

7.2.1 AMAG Pharmaceuticals Company Information

7.2.2 AMAG Pharmaceuticals Introduction and Business Overview

7.2.3 AMAG Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AMAG Pharmaceuticals Brompheniramine Product Offerings

7.2.5 AMAG Pharmaceuticals Recent Development

7.3 PAI

7.3.1 PAI Company Information

7.3.2 PAI Introduction and Business Overview

7.3.3 PAI Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 PAI Brompheniramine Product Offerings

7.3.5 PAI Recent Development

7.4 USL Pharma

7.4.1 USL Pharma Company Information

7.4.2 USL Pharma Introduction and Business Overview

7.4.3 USL Pharma Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 USL Pharma Brompheniramine Product Offerings

7.4.5 USL Pharma Recent Development

7.5 Watson Laboratories

7.5.1 Watson Laboratories Company Information

7.5.2 Watson Laboratories Introduction and Business Overview

7.5.3 Watson Laboratories Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Watson Laboratories Brompheniramine Product Offerings

7.5.5 Watson Laboratories Recent Development

7.6 Teva

7.6.1 Teva Company Information

7.6.2 Teva Introduction and Business Overview

7.6.3 Teva Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Teva Brompheniramine Product Offerings

7.6.5 Teva Recent Development

7.7 Ivax Pharmaceuticals

7.7.1 Ivax Pharmaceuticals Company Information

7.7.2 Ivax Pharmaceuticals Introduction and Business Overview

7.7.3 Ivax Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Ivax Pharmaceuticals Brompheniramine Product Offerings

7.7.5 Ivax Pharmaceuticals Recent Development

7.8 Newtron Pharmaceuticals

7.8.1 Newtron Pharmaceuticals Company Information

7.8.2 Newtron Pharmaceuticals Introduction and Business Overview

7.8.3 Newtron Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Newtron Pharmaceuticals Brompheniramine Product Offerings

7.8.5 Newtron Pharmaceuticals Recent Development

7.9 Nexgen Pharma

7.9.1 Nexgen Pharma Company Information

7.9.2 Nexgen Pharma Introduction and Business Overview

7.9.3 Nexgen Pharma Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Nexgen Pharma Brompheniramine Product Offerings

7.9.5 Nexgen Pharma Recent Development

7.10 Endo International

7.10.1 Endo International Company Information

7.10.2 Endo International Introduction and Business Overview

7.10.3 Endo International Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Endo International Brompheniramine Product Offerings

7.10.5 Endo International Recent Development

7.11 Novartis

7.11.1 Novartis Company Information

7.11.2 Novartis Introduction and Business Overview

7.11.3 Novartis Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Novartis Brompheniramine Product Offerings

7.11.5 Novartis Recent Development

7.12 Eon Pharma

7.12.1 Eon Pharma Company Information

7.12.2 Eon Pharma Introduction and Business Overview

7.12.3 Eon Pharma Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Eon Pharma Brompheniramine Product Offerings

7.12.5 Eon Pharma Recent Development

7.13 Merck

7.13.1 Merck Company Information

7.13.2 Merck Introduction and Business Overview

7.13.3 Merck Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Merck Brompheniramine Product Offerings

7.13.5 Merck Recent Development

7.14 Tanta Pharmaceuticals

7.14.1 Tanta Pharmaceuticals Company Information

7.14.2 Tanta Pharmaceuticals Introduction and Business Overview

7.14.3 Tanta Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Tanta Pharmaceuticals Brompheniramine Product Offerings

7.14.5 Tanta Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Brompheniramine Industrial Chain

8.2 Brompheniramine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Brompheniramine Sales Model

8.5.2 Sales Channel

8.5.3 Brompheniramine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Newtron Pharmaceuticals

Tanta Pharmaceuticals

List of Tables

Table 1. Brompheniramine Market Trends

Table 2. Brompheniramine Market Drivers & Opportunity

Table 3. Brompheniramine Market Challenges

Table 4. Brompheniramine Market Restraints

Table 5. Global Brompheniramine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Brompheniramine Revenue Market Share by Company (2019-2024)

Table 7. Global Brompheniramine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Brompheniramine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Brompheniramine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Brompheniramine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Brompheniramine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Brompheniramine

Table 13. Global Brompheniramine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brompheniramine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Brompheniramine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Brompheniramine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Brompheniramine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Brompheniramine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Brompheniramine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Brompheniramine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Brompheniramine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Brompheniramine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Brompheniramine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Brompheniramine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Brompheniramine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Brompheniramine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Brompheniramine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Brompheniramine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Brompheniramine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Brompheniramine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Brompheniramine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Brompheniramine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Brompheniramine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Brompheniramine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Brompheniramine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Brompheniramine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Brompheniramine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Brompheniramine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Brompheniramine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Brompheniramine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Brompheniramine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Brompheniramine Sales Value by Region (2019-2024) & (%)

Table 44. Global Brompheniramine Sales Value by Region (2025-2030) & (%)

Table 45. Global Brompheniramine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Brompheniramine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Brompheniramine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Brompheniramine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Brompheniramine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Brompheniramine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Brompheniramine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Brompheniramine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Brompheniramine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Brompheniramine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Brompheniramine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Brompheniramine Sales Volume, (2025-2030) & (K Units)

Table 57. Pfizer Company Information

Table 58. Pfizer Introduction and Business Overview

Table 59. Pfizer Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Pfizer Brompheniramine Product Offerings

Table 61. Pfizer Recent Development

Table 62. AMAG Pharmaceuticals Company Information

Table 63. AMAG Pharmaceuticals Introduction and Business Overview

Table 64. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. AMAG Pharmaceuticals Brompheniramine Product Offerings

Table 66. AMAG Pharmaceuticals Recent Development

Table 67. PAI Company Information

Table 68. PAI Introduction and Business Overview

Table 69. PAI Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. PAI Brompheniramine Product Offerings

Table 71. PAI Recent Development

Table 72. USL Pharma Company Information

Table 73. USL Pharma Introduction and Business Overview

Table 74. USL Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. USL Pharma Brompheniramine Product Offerings

Table 76. USL Pharma Recent Development

Table 77. Watson Laboratories Company Information

Table 78. Watson Laboratories Introduction and Business Overview

Table 79. Watson Laboratories Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Watson Laboratories Brompheniramine Product Offerings

Table 81. Watson Laboratories Recent Development

Table 82. Teva Company Information

Table 83. Teva Introduction and Business Overview

Table 84. Teva Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Teva Brompheniramine Product Offerings

Table 86. Teva Recent Development

Table 87. Ivax Pharmaceuticals Company Information

Table 88. Ivax Pharmaceuticals Introduction and Business Overview

Table 89. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Ivax Pharmaceuticals Brompheniramine Product Offerings

Table 91. Ivax Pharmaceuticals Recent Development

Table 92. Newtron Pharmaceuticals Company Information

Table 93. Newtron Pharmaceuticals Introduction and Business Overview

Table 94. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Newtron Pharmaceuticals Brompheniramine Product Offerings

Table 96. Newtron Pharmaceuticals Recent Development

Table 97. Nexgen Pharma Company Information

Table 98. Nexgen Pharma Introduction and Business Overview

Table 99. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Nexgen Pharma Brompheniramine Product Offerings

Table 101. Nexgen Pharma Recent Development

Table 102. Endo International Company Information

Table 103. Endo International Introduction and Business Overview

Table 104. Endo International Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Endo International Brompheniramine Product Offerings

Table 106. Endo International Recent Development

Table 107. Novartis Company Information

Table 108. Novartis Introduction and Business Overview

Table 109. Novartis Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Novartis Brompheniramine Product Offerings

Table 111. Novartis Recent Development

Table 112. Eon Pharma Company Information

Table 113. Eon Pharma Introduction and Business Overview

Table 114. Eon Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Eon Pharma Brompheniramine Product Offerings

Table 116. Eon Pharma Recent Development

Table 117. Merck Company Information

Table 118. Merck Introduction and Business Overview

Table 119. Merck Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Merck Brompheniramine Product Offerings

Table 121. Merck Recent Development

Table 122. Tanta Pharmaceuticals Company Information

Table 123. Tanta Pharmaceuticals Introduction and Business Overview

Table 124. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Tanta Pharmaceuticals Brompheniramine Product Offerings

Table 126. Tanta Pharmaceuticals Recent Development

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Brompheniramine Downstream Customers

Table 130. Brompheniramine Distributors List

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Brompheniramine Product Picture

Figure 2. Global Brompheniramine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Brompheniramine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Brompheniramine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Brompheniramine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Brompheniramine Report Years Considered

Figure 7. Global Brompheniramine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Brompheniramine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Brompheniramine Revenue in 2023

Figure 10. Brompheniramine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oral Solution Picture

Figure 12. Tablet Picture

Figure 13. Global Brompheniramine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Brompheniramine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Brompheniramine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Brompheniramine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Brompheniramine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Drug Store

Figure 20. Global Brompheniramine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Brompheniramine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Brompheniramine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Brompheniramine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Brompheniramine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Brompheniramine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Brompheniramine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Brompheniramine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Brompheniramine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Brompheniramine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Brompheniramine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Brompheniramine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Brompheniramine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Brompheniramine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Brompheniramine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Brompheniramine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Brompheniramine Sales Volume (%), (2019-2030)

Figure 37. United States Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Brompheniramine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Brompheniramine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Brompheniramine Sales Value by Application (%), 2023 VS 2030

Figure 58. Brompheniramine Industrial Chain

Figure 59. Brompheniramine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions